PharmaKinetics Laboratories Inc.

BY THE NUMBERS

October 12, 1991

This Baltimore-based tester of generic drugs, which is now operating in Chapter 11 bankruptcy, posted an $8.3 million loss for the quarter that ended June 30 as revenues dropped to half of last year's levels.

The loss for its fourth fiscal quarter brought PharmaKinetics' losses for fiscal 1991 to $10.4 million. That compares with a $3.8 million loss in fiscal 1990.

The loss in the fourth quarter stemmed from $6.7 million in expenses linked to the company's Chapter 11 filing in November 1990, PharmaKinetics said in a prepared statement.

PharmaKinetics attributed the slide to several adverse events, in

cluding its bankruptcy filing and a federal investigation of the firm's former chief scientific officer.

In its earnings statement, the company also said its bankruptcy reorganization filing should be completed soon.

Three months ended 6/30/91

Revenue ... ... ... ... Net ... ... ... ... Share

'91 3,048,663 ... ... (8,350,286) ... ... (0.83)

'90 6,459,959 ... ... (3,078,750) ... ... (0.33)

% change -52.8 ... ... -- ... ... ... ... .. --

Twelve months ended 6/30/91

Revenue ... ... ... ... Net ... ... ... ... Share

'91 16,227,055 ... ... (10,432,989) ... ... (1.03)

'90 27,131,007 ... ... (3,768,483) ... ... (0.40)

% change -40.2 ... ... .. -- ... ... ... ... --

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.